Get regular updates to your inbox.
Children successfully treated for a cancer who undergo thyroid surgery for a secondary thyroid disease have a similar risk of surgical complications, such as permanent hypoparathyroidism, as children without a previous cancer, a single-center study in the U.S. shows. These findings add to an ongoing discussion of whether cancer…
Read more
The National Organization for Rare Disorders’ (NORD) “Living Rare, Living Stronger Patient and Family Forum” is back in person on June 26 for a day of learning and networking in Cleveland, Ohio. The event, which brings together the rare disease community, will take place at the InterContinental Cleveland Conference…
Daily treatment with AZP-3601, Amolyt Pharma’s investigational therapy for hypoparathyroidism, was well tolerated and allowed patients to discontinue standard supplement treatment, early data from a Phase 2a trial show. The treatment also rapidly normalized 24-hour urine calcium levels and improved bone health. The findings, from a first group of…
Get regular updates to your inbox.
